Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 1
2018 2
2019 4
2020 3
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

8 results
Results by year
Filters applied: . Clear all
Page 1
B7-H3 in Cancer - Beyond Immune Regulation.
Flem-Karlsen K, Fodstad Ø, Tan M, Nunes-Xavier CE. Flem-Karlsen K, et al. Trends Cancer. 2018 Jun;4(6):401-404. doi: 10.1016/j.trecan.2018.03.010. Epub 2018 Apr 20. Trends Cancer. 2018. PMID: 29860983 Review.
B7-H3 Immune Checkpoint Protein in Human Cancer.
Flem-Karlsen K, Fodstad Ø, Nunes-Xavier CE. Flem-Karlsen K, et al. Curr Med Chem. 2020;27(24):4062-4086. doi: 10.2174/0929867326666190517115515. Curr Med Chem. 2020. PMID: 31099317 Review.
Soluble AXL as a marker of disease progression and survival in melanoma.
Flem-Karlsen K, Nyakas M, Farstad IN, McFadden E, Wernhoff P, Jacobsen KD, Flørenes VA, Mælandsmo GM. Flem-Karlsen K, et al. PLoS One. 2020 Jan 9;15(1):e0227187. doi: 10.1371/journal.pone.0227187. eCollection 2020. PLoS One. 2020. PMID: 31917795 Free PMC article.
A Three-dimensional Ex Vivo Viability Assay Reveals a Strong Correlation Between Response to Targeted Inhibitors and Mutation Status in Melanoma Lymph Node Metastases.
Flørenes VA, Flem-Karlsen K, McFadden E, Bergheim IR, Nygaard V, Nygård V, Farstad IN, Øy GF, Emilsen E, Giller-Fleten K, Ree AH, Flatmark K, Gullestad HP, Hermann R, Ryder T, Wernhoff P, Mælandsmo GM. Flørenes VA, et al. Among authors: flem karlsen k. Transl Oncol. 2019 Jul;12(7):951-958. doi: 10.1016/j.tranon.2019.04.001. Epub 2019 May 13. Transl Oncol. 2019. PMID: 31096111 Free PMC article.